{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:44:49Z","timestamp":1792061089607,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11886-022-01727-z","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:17:10Z","timestamp":1659014230000},"page":"1077-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Emerging Genotype\u2013Phenotype Associations in Dilated Cardiomyopathy"],"prefix":"10.1007","volume":"24","author":[{"given":"Joyce N.","family":"Njoroge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Mangena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaka","family":"Aribeana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria N.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"W Committee","year":"2021","unstructured":"Committee W, Maddox TM, Januzzi JL Jr, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77:772\u2013810.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731\u201348.","journal-title":"Circ Res"},{"key":"1727_CR3","volume-title":"Clinical cardiology: current practice guidelines","author":"DG Katritsis","year":"2013","unstructured":"Katritsis DG, Katritsis D, Gersh BJ, John Camm A. Clinical cardiology: current practice guidelines. Oxford University Press; 2013."},{"key":"1727_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807\u201316.","journal-title":"Circulation"},{"key":"1727_CR5","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850\u20138.","journal-title":"Eur Heart J"},{"key":"1727_CR6","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134:e579\u2013646.","journal-title":"Circulation"},{"key":"1727_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"H-P Schultheiss","year":"2019","unstructured":"Schultheiss H-P, Fairweather D, Caforio ALP, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5:32.","journal-title":"Dilated cardiomyopathy Nat Rev Dis Primers"},{"key":"1727_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2021.24674","volume":"327","author":"GS Huggins","year":"2022","unstructured":"Huggins GS, Kinnamon DD, Haas GJ, et al. Prevalence and cumulative risk of familial idiopathic dilated cardiomyopathy. JAMA. 2022;327:454\u201363.","journal-title":"JAMA"},{"key":"1727_CR9","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","volume":"78","author":"L Escobar-Lopez","year":"2021","unstructured":"Escobar-Lopez L, Ochoa JP, Mirelis JG, et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2021;78:1682\u201399.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","volume":"28","author":"AC Sturm","year":"2013","unstructured":"Sturm AC, Hershberger RE. Genetic testing in cardiovascular medicine: current landscape and future horizons. Curr Opin Cardiol. 2013;28:317\u201325.","journal-title":"Curr Opin Cardiol"},{"key":"1727_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCGEN.120.003031","volume":"13","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot JAJ, Hazebroek MR, Krapels IPC, et al. Implications of genetic testing in dilated cardiomyopathy. Circ Genom Precis Med. 2020;13:476\u201387.","journal-title":"Circ Genom Precis Med"},{"key":"1727_CR12","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Mazzarotto F, Tayal U, Buchan RJ, et al.\u00a0Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation. 2020;141:387\u2013398.\u00a0This large DCM cohort sequencing study of over 2500 probands identified genes and variants most relevant for DCM genetic testing.","DOI":"10.1161\/CIRCULATIONAHA.119.037661"},{"key":"1727_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/gim.2013.204","volume":"16","author":"TJ Pugh","year":"2014","unstructured":"Pugh TJ, Kelly MA, Gowrisankar S, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014;16:601\u20138.","journal-title":"Genet Med"},{"key":"1727_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2016","unstructured":"Walsh R, Thomson KL, Ware JS, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016;19:192\u2013203.","journal-title":"Genet Med"},{"key":"1727_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan E, Peterson L, Ai T, et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation. 2021;144:7\u201319.","journal-title":"Circulation"},{"key":"1727_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euac030","author":"AAM Wilde","year":"2022","unstructured":"Wilde AAM, Semsarian C, M\u00e1rquez MF, et al. European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace. 2022. https:\/\/doi.org\/10.1093\/europace\/euac030.","journal-title":"Europace"},{"key":"1727_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/humu.24004","volume":"41","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot JAJ, Vanhoutte EK, Claes GRF, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020;41:1091.","journal-title":"Hum Mutat"},{"key":"1727_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.117.001959","author":"A Brodehl","year":"2017","unstructured":"Brodehl A, Gaertner-Rommel A, Milting H. (Filamin-C): a new(er) player in the field of genetic cardiomyopathies. Circ Cardiovasc Genet. 2017. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.001959.","journal-title":"Circ Cardiovasc Genet"},{"key":"1727_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106394","author":"F Brun","year":"2020","unstructured":"Brun F, Gigli M, Graw SL, et al. FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy. J Med Genet. 2020. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106394.","journal-title":"J Med Genet"},{"key":"1727_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay RL, Graw SL, Sinagra G, et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures. JACC Clin Electrophysiol. 2018;4:504\u201314.","journal-title":"JACC Clin Electrophysiol"},{"key":"1727_CR21","doi-asserted-by":"publisher","unstructured":"\u2022 Gigli M, Stolfo D, Graw SL, et al.\u00a0Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants. Circulation. 2021.\u00a0https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053521. Gigli et al. detected the arrhythmogenic phenotype associated with FLNC truncating variants independent of left ventricular dysfunction, an example of high risk cardiomyopathy with heterogenous clinical presentations.","DOI":"10.1161\/CIRCULATIONAHA.121.053521"},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.120.317076","volume":"129","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Paulo JA, Toepfer CN, et al. Filamin C cardiomyopathy variants cause protein and lysosome accumulation. Circ Res. 2021;129:751\u201366.","journal-title":"Circ Res"},{"key":"1727_CR23","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16:e301\u201372.","journal-title":"Heart Rhythm"},{"key":"1727_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ejhf.16","volume":"16","author":"M Merlo","year":"2014","unstructured":"Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16:317\u201324.","journal-title":"Eur J Heart Fail"},{"key":"1727_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-041217-010932","volume":"70","author":"CA James","year":"2019","unstructured":"James CA, Calkins H. Arrhythmogenic right ventricular cardiomyopathy: progress toward personalized management. Annu Rev Med. 2019;70:1\u201318.","journal-title":"Annu Rev Med"},{"key":"1727_CR26","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41591-021-01505-4","volume":"27","author":"CY Ho","year":"2021","unstructured":"Ho CY, Day SM, Axelsson A, et al. Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med. 2021;27:1818\u201324.","journal-title":"Nat Med"},{"key":"1727_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","volume":"66","author":"MR Hazebroek","year":"2015","unstructured":"Hazebroek MR, Moors S, Dennert R, et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification. J Am Coll Cardiol. 2015;66:1313\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00761","author":"S Crasto","year":"2020","unstructured":"Crasto S, My I, Di Pasquale E. The broad spectrum of LMNA cardiac diseases: from molecular mechanisms to clinical phenotype. Front Physiol. 2020. https:\/\/doi.org\/10.3389\/fphys.2020.00761.","journal-title":"Front Physiol"},{"key":"1727_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/heartjnl-2017-312338","volume":"104","author":"G Captur","year":"2018","unstructured":"Captur G, Arbustini E, Bonne G, et al. Lamin and the heart. Heart. 2018;104:468\u201379.","journal-title":"Heart"},{"key":"1727_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI200419448","volume":"113","author":"V Nikolova","year":"2004","unstructured":"Nikolova V, Leimena C, McMahon AC, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A\/C-deficient mice. J Clin Invest. 2004;113:357\u201369.","journal-title":"J Clin Invest"},{"key":"1727_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.117.002004","author":"G Sinagra","year":"2017","unstructured":"Sinagra G, Dal Ferro M, Merlo M. Lamin A\/C cardiomyopathy: cutting edge to personalized medicine. Circ Cardiovasc Genet. 2017. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.002004.","journal-title":"Circ Cardiovasc Genet"},{"key":"1727_CR32","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","volume":"68","author":"S Kumar","year":"2016","unstructured":"Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J Am Coll Cardiol. 2016;68:2299\u2013307.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR33","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e190\u2013252.","journal-title":"Heart Rhythm"},{"key":"1727_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","volume":"39","author":"NE Hasselberg","year":"2018","unstructured":"Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP, Edvardsen T, Haugaa KH. Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853\u201360.","journal-title":"Eur Heart J"},{"key":"1727_CR35","first-page":"263","volume":"37","author":"D Yermakovich","year":"2018","unstructured":"Yermakovich D, Sivitskaya L, Vaikhanskaya T, Danilenko N, Motuk I. Novel desmoplakin mutations in familial Carvajal syndrome. Acta Myol. 2018;37:263.","journal-title":"Acta Myol"},{"key":"1727_CR36","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","volume":"41","author":"D Corrado","year":"2020","unstructured":"Corrado D, van Tintelen PJ, McKenna WJ, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41:1414\u201329.","journal-title":"Eur Heart J"},{"key":"1727_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/europace\/euab183","volume":"24","author":"W Wang","year":"2022","unstructured":"Wang W, Murray B, Tichnell C, Gilotra NA, Zimmerman SL, Gasperetti A, Scheel P, Tandri H, Calkins H, James CA. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. Europace. 2022;24:268\u201377.","journal-title":"Europace"},{"key":"1727_CR38","doi-asserted-by":"publisher","unstructured":"\u2022Smith ED, Lakdawala NK, Papoutsidakis N, et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044934. DSP, previously associated with predominantly right ventricular arrhythmogenic cardiomyopathy, is described in association with a unique left ventricular fibrotic and inflammatory cardiomyopathy in this study.","DOI":"10.1161\/CIRCULATIONAHA.119.044934"},{"key":"1727_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005700","volume":"12","author":"TM Hey","year":"2019","unstructured":"Hey TM, Rasmussen TB, Madsen T, Aagaard MM, Harbo M, M\u00f8lgaard H, M\u00f8ller JE, Eiskj\u00e6r H, Mogensen J. Pathogenic RBM20-variants are associated with a severe disease expression in male patients with dilated cardiomyopathy. Circ Heart Fail. 2019;12: e005700.","journal-title":"Circ Heart Fail"},{"key":"1727_CR40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo W, Schafer S, Greaser ML, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18:766\u201373.","journal-title":"Nat Med"},{"key":"1727_CR41","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1172\/JCI74523","volume":"124","author":"H Maatz","year":"2014","unstructured":"Maatz H, Jens M, Liss M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124:3419\u201330.","journal-title":"J Clin Invest"},{"key":"1727_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","volume":"54","author":"KM Brauch","year":"2009","unstructured":"Brauch KM, Karst ML, Herron KJ, de Andrade M, Pellikka PA, Rodeheffer RJ, Michels VV, Olson TM. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol. 2009;54:930\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1752-8062.2010.00198.x","volume":"3","author":"D Li","year":"2010","unstructured":"Li D, Morales A, Gonzalez-Quintana J, Norton N, Siegfried JD, Hofmeyer M, Hershberger RE. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci. 2010;3:90\u20137.","journal-title":"Clin Transl Sci"},{"key":"1727_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","author":"VN Parikh","year":"2019","unstructured":"Parikh VN, Caleshu C, Reuter C, et al. Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy. Circ Heart Fail. 2019. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005371.","journal-title":"Circ Heart Fail"},{"key":"1727_CR45","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","volume":"138","author":"MMG van den Hoogenhof","year":"2018","unstructured":"van den Hoogenhof MMG, Beqqali A, Amin AS, et al. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling. Circulation. 2018;138:1330\u201342.","journal-title":"Circulation"},{"key":"1727_CR46","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41591-020-1087-x","volume":"26","author":"JW Schneider","year":"2020","unstructured":"Schneider JW, Oommen S, Qureshi MY, et al. Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs. Nat Med. 2020;26:1788\u2013800.","journal-title":"Nat Med"},{"key":"1727_CR47","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1038\/s41467-021-26623-y","volume":"12","author":"AM Fenix","year":"2021","unstructured":"Fenix AM, Miyaoka Y, Bertero A, et al. Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies. Nat Commun. 2021;12:6324.","journal-title":"Nat Commun"},{"key":"1727_CR48","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1038\/s41598-019-39911-x","volume":"9","author":"O Akinrinade","year":"2019","unstructured":"Akinrinade O, Heli\u00f6 T, Lekanne Deprez RH, et al. Relevance of titin missense and non-frameshifting insertions\/deletions variants in dilated cardiomyopathy. Sci Rep. 2019;9:4093.","journal-title":"Sci Rep"},{"key":"1727_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCGENETICS.116.001513","volume":"9","author":"RC Deo","year":"2016","unstructured":"Deo RC. Alternative splicing, internal promoter, nonsense-mediated decay, or all three: explaining the distribution of truncation variants in titin. Circ Cardiovasc Genet. 2016;9:419\u201325.","journal-title":"Circ Cardiovasc Genet"},{"key":"1727_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.120.049997","volume":"145","author":"R Romano","year":"2022","unstructured":"Romano R, Ghahremani S, Zimmerman T, Legere N, Thakar K, Ladha FA, Pettinato AM, Hinson JT. Reading frame repair of truncation variants restores titin quantity and functions. Circulation. 2022;145:194\u2013205.","journal-title":"Circulation"},{"key":"1727_CR51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","author":"MM Akhtar","year":"2020","unstructured":"Akhtar MM, Lorenzini M, Cicerchia M, et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene. Circ Heart Fail. 2020. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006832.","journal-title":"Circ Heart Fail"},{"key":"1727_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","volume":"140","author":"CM Haggerty","year":"2019","unstructured":"Haggerty CM, Damrauer SM, Levin MG, et al. Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation. 2019;140:42\u201354.","journal-title":"Circulation"},{"key":"1727_CR53","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","volume":"70","author":"U Tayal","year":"2017","unstructured":"Tayal U, Newsome S, Buchan R, et al. Phenotype and clinical outcomes of titin cardiomyopathy. J Am Coll Cardiol. 2017;70:2264\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003389","volume":"14","author":"PN Patel","year":"2021","unstructured":"Patel PN, Ito K, Willcox JAL, et al. Contribution of noncanonical splice variants to truncating variant cardiomyopathy. Circ Genom Precis Med. 2021;14: e003389.","journal-title":"Circ Genom Precis Med"},{"key":"1727_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15823-7","author":"JP Pirruccello","year":"2020","unstructured":"Pirruccello JP, Bick A, Wang M, et al. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-15823-7.","journal-title":"Nat Commun"},{"key":"1727_CR56","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2020.01.013","volume":"75","author":"JP Pirruccello","year":"2020","unstructured":"Pirruccello JP, Bick A, Chaffin M, et al. Titin truncating variants in adults without known congestive heart failure. J Am Coll Cardiol. 2020;75:1239\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.462","author":"JS Ware","year":"2018","unstructured":"Ware JS, Amor-Salamanca A, Tayal U, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.462.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","volume":"140","author":"P Garcia-Pavia","year":"2019","unstructured":"Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic variants associated with cancer therapy-induced cardiomyopathy. Circulation. 2019;140:31\u201341.","journal-title":"Circulation"},{"key":"1727_CR59","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015;66:905\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017832","volume":"10","author":"MM Gad","year":"2021","unstructured":"Gad MM, Elgendy IY, Mahmoud AN, Saad AM, Isogai T, Sande Mathias I, Misbah Rameez R, Chahine J, Jneid H, Kapadia SR. Disparities in cardiovascular disease outcomes among pregnant and post-partum women. J Am Heart Assoc. 2021;10: e017832.","journal-title":"J Am Heart Assoc"},{"key":"1727_CR61","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","volume":"374","author":"JS Ware","year":"2016","unstructured":"Ware JS, Li J, Mazaika E, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374:233\u201341.","journal-title":"N Engl J Med"},{"key":"1727_CR62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052395","author":"R Goli","year":"2021","unstructured":"Goli R, Li J, Brandimarto J, et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052395.","journal-title":"Circulation"},{"key":"1727_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10139-0","author":"N Orphanou","year":"2021","unstructured":"Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev. 2021. https:\/\/doi.org\/10.1007\/s10741-021-10139-0.","journal-title":"Heart Fail Rev"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01727-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T15:06:16Z","timestamp":1668611176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01727-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01727-z","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"4 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"VNP is on the SAB of and receives research support from BioMarin, Inc., and has minor consulting relationships with Viz.ai, and Constantiam Biosciences. VNP also reports support from NHLBI K08HL14318503, as well as payment for UCSD genomic medicine grand rounds. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}